|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Ih-Houng Loh | William Lee | Michelle Chen | 03-6579530 | 4F, No16, Sec.2, Sheng Yi RoadZhubei, Hsinchu 30261 Taiwan, R.O.C. | 2018/07/18 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | ICARES Medicus, Inc. was founded in 2011 at Hsinchu Biomedical Science Park, Hsinchu, Taiwan as a prestigious medical device manufacturer by an entrepreneurial management team originated from AST Products, Inc. (Massachusetts, U.S.A.). With more than 70 years of combined industrial experience, the Company's vision is to create a better quality of eye health life for many people. The Company's business idea supports this vision by commercializing innovative ophthalmic products, particularly intraocular lenses and their delivery systems for cataract and refractive surgeries, while leading the way for socially conscious businesses. ICARES Medicus is an ISO9001 and ISO13485 certified company with a pipeline of high quality products that are approved by the European Union and various Food and Drug Administrations of U.S.A., China and Taiwan. The Company strives to sustain its values with new ideas and future unique products for global business growth. |
Market Information ( 2024/05/03 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
169.845 | 132.00 | 129.00 | 131.00 | -3.00 | 224 | .00 | 895 | 3 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/05/03) |
TPEx measures adopted (2024/05/03) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |